跳至主要内容
临床试验/IRCT20220516054875N1
IRCT20220516054875N1尚未招募1 期

Exploring the pharmacist's intervention for precluding the factors effecting medication adherence in Chronic Obstructive Pulmonary Diseases (COPD) following GOLD (Global Initiative for Chronic Obstructive Lungs diseases) guidelines in Pakistan

Quaid-i-Azam University , Islamabad0 个研究点目标入组 150 人开始时间: 待定最近更新:
适应症

试验速览

阶段
1 期
状态
尚未招募
发起方
入组人数
150

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 no limit(—)
性别
All

入选标准

  • Patients only attend the outpatient COPD wards, confirmed diagnosis of COPD by the hospital consultant for at least 1 year
  • Newly diagnosed patients with a forced expiratory volume in 1 s (FEV1) of 30–80% of the predicted normal value
  • Patients that hospital consultant agree that the patient is suitable for entering the trial

排除标准

  • Moderate to severe learning difficulties
  • Mobility problems, confusion, disorientation or terminal illness
  • Congestive heart failure or if they are attending a pulmonary rehabilitation programs consulting a pulmonary nurse or clinical pharmacist in the last 6 months

研究者

发起方
Quaid-i-Azam University , Islamabad

相似试验